Skip to content

Drug interactions

Epcoritamab + Ergotamine

Severity: Major

Epcoritamab and Ergotamine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Epcoritamab releases cytokines that can temporarily suppress CYP enzyme activity. This may raise ergotamine levels and the risk of vasospasm and ischemia.

What this interaction means in plain words

Epcoritamab and Ergotamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Epcoritamab belongs to Oncology; Ergotamine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Cytokine-mediated downregulation of CYP3A4 reduces ergotamine metabolism.

What to do

Avoid ergotamine around the time of epcoritamab step-up dosing and during cytokine release syndrome. If it is unavoidable, monitor closely for ergotism and use the lowest effective ergotamine dose.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Epcoritamab and Ergotamine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Epcoritamab with Ergotamine?

MediHelp rates the interaction as major. Epcoritamab and Ergotamine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Epcoritamab releases cytokines that can temporarily suppress CYP enzyme activity. This may raise ergotamine levels and the risk of vasospasm and ischemia.

How serious is the interaction between Epcoritamab and Ergotamine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid ergotamine around the time of epcoritamab step-up dosing and during cytokine release syndrome. If it is unavoidable, monitor closely for ergotism and use the lowest effective ergotamine dose.

What other medicines interact with Ergotamine?

MediHelp also lists interactions of Ergotamine with, for example, Almotriptan, Atazanavir, Clarithromycin. The full list is on the Ergotamine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in